Theme of the Congress: Managing Kidney Disease: Quality, Perfection vs. Outcome

Wednesday, 5 March 2014 There will whole one day Practical PD course for restricted number of Attendee 20-30 participants. This will include at the end two important sessions:

i. Meet the Experts and ii. PD in Arabic countries.

Time

Date

10:00 12:45

12:45 13:15

13:15 16:45

17:00 17:30

17:30 19:00

Small Theater

CNE

Coffee Break

CNE Opening

Cermoney Plenary 1

lecture Continuous

Nursing Education

Continuous Nursing

Education

10:00 – 16:45 Pre-Congress CNE / Main Hall

Moderator: Prof. Hussein Sheashaa

10:00 – 16:45 Pre-Congress Continuous Nursing Education /

Lecture Hall

10:00 –16:45 Moderator: Prof: Heba Al-Shaar 10:00 –11:00 Clinical Nephrology TBA 11:00-11:45 HD – Maintenance TBA 11:45-12:00 Coffee Break 12:00-13:00 CRRT & ICU Ib. Sobhy 13:00-14: 00 PD: Initiation & Maintained TBA 14:00-14:30 Lunch 14:30-15:30 Transplantation TBA 15:30-16:30 Practical Training TBA 16:30 – 16:45 Evaluation & Closing Remarks Heba Al. Shaar

Pre-Congress Practical Training / Entrance Hall 10:00 – 16:00

CRRT TBA Alexandria

PD Osama Al-Shaata Mansoura

HD Sherif Aziz Alexandria

USS & Kidney Biopsy Sherif Hegab Alexandria & M. Al-Shafee Alexandria

17:00 – 17:30 Opening Ceremony / Main Hall

Chairpersons: Saeed M. G. Al-Ghamdi, Tarek El-Baz

17:30 – 19:00 Plenary Session / Main Hall

P1: Nephrology 2020 Rashad Barsoum Egypt P2: Role of Antibody in transplant rejection M. Al Sayeg Lebanon

19:00 – 20:00 Oriental Music / Main Hall

Thursday, 6 March 2014

Time

Date

08:00 09:00

0900 10:45

10:45 12:15

12:30 13:30

13:30 15:00

15:00 16:00

16:00 17:30

17:30 19:00

Main Hall

Glo

bal

Kid

ney

Aca

dem

y (G

KA

/OLA

)

Ple

nar

y

Session (S1-DKD)

No

vart

is In

du

stri

al s

ypo

siu

m Session

(S5-G)

Am

gen

Ind

ust

rial

syp

osi

um

Ple

nar

y

CP

C -

1

Small Theater

Session (S2-Tx)

Session (S6-Tx)

Lecture Session (S3-PD)

Session (S7-Bone)

A Session

(S4-Case)

Session (S8-Free

Communications)

Greco Roman

AstraZeneca

industrial lunch

09:00 – 10:45 Plenary Session / Main Hall

Chairpersons: P3: TBA Saeed Al-Ghamdi KSA P4: CKD; Screen or Not- How, Whom and Who? Richard J Glassock USA P5: Membranous nephropathy: from the bench to the bedside? TBA TBA

10:45 – 12:15 Scientific Session (S1) / Main Hall

Diabetic Kidney Disease Moderator: Amr Ebied

1) Immune-Inflammation in DKD; pathogenic role and its therapeutic implications. Amr Ebied Egypt

2) FGF-23: role in progression of DKD.

TBA TBA 3) Tubulo-interstitial fibrosis in DKD. Update in the pathogenesis.

TBA TBA 4) Treatment of Diabetes in CKD – Stage 1-4

Yahiya Ghana Egypt 5) New therapeutic options in DKD

TBA TBA

10:45 – 12:15 Scientific Session (S2) / Small Theater

Transplantation – 1 Moderator: Adel Bakr

1) Bridge to transplant Marwan Al-Masry Lebanon 2) T-reg in Renal Transplant M. Sayeg USA 3) Desensitization TBA TBA 4) Quiz Ahmed Donia Egypt

10:45 – 12:15 Scientific Session (S3) / Lecture Hall

Peritoneal Dialysis Moderator: Salah Naga

1) PD in the challenging population Joanne Bergman Canada 2) The benefits of the new PD Solutions Ali Aboalfa Lebanon 3) Peritonitis management in PD patients: 2013 update Yassin El Shahat UAE 4) PD in AKI Abdalla Alhawish KSA 5) New strategies for growth of PD program Khalid AboSeif Egypt

10:45 – 12:15 Scientific Session (S4) / Hall A

Case presentation Moderators: A. Samy, Hyam AlAggan, Sohair Al-Lakany

Each Case will be selected to presented in 15 min (12 min ppt & 3 min for discussion)

12:30 -13:30 Novartis Industrial Symposium / Main Hall

13:30 – 15:00 Scientific Session (S5) / Main Hall

Glomerular Diseases Moderator: Iman Al-Gohary

The podocytopathies: molecular mechanisms & clinical implications Neveen A Soliman Egypt Immunotactoid vs. Fibrillary GN – A management problem Hayam Al Aggan Egypt Treatment of FSGS – A mysterious Disease to treat? R. Glassock USA New therapy for Glomerular Diseases "Practical or Theoretical – Fact or Fiction" Muhammad Sobh Egypt Stem Cell Therapy in Glomerular Disease: Fact or Fiction? Gamal Al-Saady Egypt

13:30 – 15:00 Scientific Session (S6) / Small Theater

Transplantation – 2 Moderator: Adel Bakr

5) Optimizing graft outcome in renal transplantation: Does Pharmacogenetics has a role?

Antoine Barbari Lebanon 6) Induction in Renal Transplantation – How; When, Which to use? -Does it really have a value? TBA TBA 7) BK in Renal Transplantation - Update

M Ghonimat Jordan 8) Transplant forum

Aymen Refaie Egypt

13:30 – 15:00 Scientific Session (S7) / Lecture Hall

CKD-MBD Moderator: Saeed Al-Ghamdi

1) The initiative factor for CKD-MBD – Does it matter to Know?

TBA TBA 2) Bone of Glass & Heart of Stone

Tarek ElBaz Egypt 3) Phosphate Binders in CKD

Magdy Al Sharkawy Egypt 4) Intravenous alfacalcidol in CKD MBD

Kiriaki Stamatelou Greece 5) (KDIGO) Guidelines for CKD-MBD: Implementation and Adaptation for Practice in the Middle East Countries.

Mona Al Rukhaimi UAE

13:30 – 15:00 Scientific Session (S8) / Hall A Free Paper Communications

Moderators: A. Samy, Hyam AlAggan, Sohair Al-Lakany Chairpersons:

Mini Lecture: Kidney stone disease, epidemiology and latest therapy

Kiriaki Stamatelou Greece

6 papers will be presented. Each paper will be presented for 15min (12 min ppt & 3 min discussion).

15:00 -16:00 Amgen Industrial Symposium / Main Hall

16:00 – 17:30 Plenary Session / Main Hall

Chairpersons: P6: GFR and Albuminuria : Risk Predictors for CKD?

M. El-Nahas UK P7: Advances in immunosuppression therapy monitoring

Marwan Al-Masry Lebnon P8: Nephrotoxicity ,clinical applications

Marc deBroe Belgium

17:30 – 19:00 CPC -1 / Main Hall

Moderators: Clinical Discussant: Assem Al-Sherif

Pathological Discussant: Lina Assad 1st Case: Nahed Baddour Alexandria 2nd Case: TBA TBA 3rd Case: Issam Francis Kuwait 4th Case: TBA Jordon

21:00 – 23:00 Faculty Dinner

Friday, 7 March 2014

Time Date

09:00 10:30

10:30 12:00

12:00 1300

13:00 14:00

14:00 15:30

15:30 16:30

16:30 18:00

Main Hall

Ple

nar

y

Session (S9-HTN)

Coffee Break & Jomaa prayer

San

ofi

ind

ust

ial

sym

po

siu

m

ISN/EDTA

ind

ust

rial

sym

po

siu

m

CP

C -

2 Small

Theater Session

(S10-HD1)

Lecture Session

(S11-Path)

A Session

(S12-Junior)

09:00 – 10:30 Plenary Session / Main Hall

Chair Persons:

P9: Sugar, Uric Acid, Diabetes and Obesity – Do we have a link? RJ Johnson USA

P10: Choosing the Right Dialysis Modality for Each Patient: PD versus HD

Joanne Bergman Canada P11: Maintenance Immunosuppression in Renal Transplantation; does it affect Graft survival?

Maher F. Ramzy Egypt

10:30 – 12:00 Scientific Session (S9) / Main Hall

Hypertension Moderator: Omar Al-Kashab

1) Variability of blood pressure in CKD - impact on prescription

TBA TBA 2) Home blood pressure versus office blood pressure

TBA TBA 3) New guidelines in blood pressure goals in CKD

Omar Al-Kashab Egypt Debate: 4) RAS inhibitors/blockers is the first antihypertensive choice in CKD Pros

Richard Johnson USA 5) RAS inhibitors/blockers is not the first antihypertensive choice in CKD Cons

Meguid El-Nahas UK Rebuttal 5 min each Vote 5 min

10:30 – 12:00 Scientific Session (S10) / Small Theater

Hemo-Dialysis/CRRT-1 Moderator: Waleed Masoud

1) Intra and inter dialytic Na and volume control

Sohair Al-Lakany Egypt 2) Optimizing removal of middle and large uremic toxins: role of membrane, treatment modality and time

B. Canaud France 3) Are we preparing the patient for hemodialysis in Egypt: Preparation of the patient for hemodialysis:

Guidelines vs. TBA TBA Egypt vs. Waleed Masoud Egypt Voting TBA TBA

4) AVF Button Technique

M. Jadoul France

10:30 – 12:00

Scientific Session (S11) / Lecture Hall Renal Pathology

Moderator: Issam Francis, Lina Assad, Wesam Ismail Chairpersons:

1) C3 GN – Update in MPGN Classification– Pathological View Fatma Al Huseiny Egypt 2) Interstitial Nephritis – pathological entity without boundaries

TBA TBA 3) Hereditary Nephritis – Does Pathology help?

TBA TBA 4) Pathological Case (1)

Lina Assad Syria

5) Pathological Case (2) Wesam Ismail Egypt

10:30 – 12:00 Scientific Session (S12) / Hall A

Free Junior Communications Moderators: Hussein Sheashaa, M. Salah, A. Adam

9 free junior communications will be selected to be presented.

Each presentation will take 10 min (8 min ppt & 2 min Discussion)

12:00 – 13:00 Coffee Break & Gomaa Pray

13:00 - 14:00

Sanofi Industrial Symposium / Main Hall

14:00 – 15:30 ISN / EDTA Satellite Session / Main Hall

Chairperson: G Remuzzi Italy

DOPPS – Update Michel Jadoul Belgium

Onco-nephrology: glomerular diseases with cancer.

TBA TBA Donor / Recipient relationship in renal transplantation in the Arabic world

Mona Al Rukhaimi UAE "0 by 25" A human rights case for health equity: acute kidney failure in poor countries should no longer be a death sentence"

G Remuzzi Italy

15:30 - 16:30 Industrial Symposium / Main Hall

16:30 – 18:00 CPC -2 / Main Hall

Moderators: Clinical Discussant: Riyad Said Jordon

Pathological Discussant: Issam Francis Kuwait 5th Case: TBA Mansoura 6th Case: TBA Cairo 7th Case: TBA KSA 8th Case: TBA Ein Shams

21:00 – 23:00 Gala Dinner Friday

Saturday, 8 March 2014

Time

Date

0900 10:45

10:45 11:45

11:45 12:15

12:15 14:15

14:15

Main Hall

Ple

nar

y C

losi

ng

Rem

arks

Kid

ney

Fo

rum

Co

ffee

Bre

ak

Session (S13-Prog)

Dep

artu

re

Small Theater Session

(S14-Epidemiology)

Lecture Session

(S15-WKD)

A Session

(S16-HD2-CRRT)

09:00 – 10:45 Plenary Session / Main Hall

Chairpersons:

P12: The impact of viruses and their treatment on the kidney Michel Jadoul Belgium

P13: APK; still Unsolved Management Problem?

G. Remuzzi Italy P14: The Transplantation in the Arabic World

Faisel Shaeen KSA

10:45 – 11:45 Kidney Forum / Main Hall Chairpersons: R. Barsoum

Clinical Discussant: M. Jadoul & Antoine Barbari Pathological Discussant: Mona Salem & Wesam Ismail

11:45 – 12:00

Closing Remarks / Main Hall Charipersons: Tarek ElBaz, G. Remuzzi

12:15 – 14:15 Scientific Session (S13) / Main Hall

Progression of CKD - CKD: Contrarian Views! Moderator: Abdel Meguid El-Nahas

1) Progression, remission and regression of chronic renal diseases and the case of kidney self-repair

G. Remuzzi Italy 2) Reflections on with Current CKD Guidelines

Richard Glassock USA

3) CKD – Care Pathway? Marc de Broe Belgium

4) eGFR: What for?

Abdel Meguid El Nahas UK 5) Genetics of CKD; Does it help to Manage Progression?

Neveen Soliman ElShakhs Egypt

12:15 – 14:15 Scientific Session (S14) / Small Theater

Epidemiology of Kidney Diseases Moderator: Hala El-Wakeel

1) Non-Communicable diseases as global and regional problems.

Alaa Alwan EMRO-WHO 2) Screening for CKD in KSA as a part of the Arabic World.

TBA TBA 3) Kidney protection program in Alexandria region "KIPP-Alex".

Hala El-Wakil Egypt 4) Control Program for non-communicable diseases- Environmental-Health Link.

Moustafa Mourad HIPH- Alex

12:15 – 14:15 Scientific Session (S15) / Lecture Hall

WKD – 2014 – “ CHRONIC KIDNEY DISEASE AND AGING”. Moderator: Hany Hafez

Chairpersons: 1) Introduction :Various scientific activities of ESNT

Tarek El-Baz Egypt 2) What Did World Kidney Days added (Flash back of last 5 years activities)

Mohamed Hani Hafez Egypt

3) How Aging Affects Normal Kidneys. TBA TBA

4) CKD patients & aging : specific Considerations for CKD, Dialysis & Transplantation populations

Richard Glassock USA

12:15 – 14:15 Scientific Session (S16) / Hall A

Hemo-Dialysis- 2 AKI- CRRT- ICU Nephrology Moderator: Montassar Zeid

Chairpersons: Bioimpedence in HD Ahmed Samy ElBelbessy Egypt Concurrent CRRT and therapeutic plasma exchange Montassar Zeid Egypt Extended indications for CRRT Saeed Khamis Egypt Dialysis dose controversy: what role for Kt/V in future ? G Canaud France